Advanced search
Publication Cover
Future Microbiology Volume 5, 2010 - Issue 9
Submit an article Journal homepage
1,037
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Treatment of Visceral Leishmaniasis in 2010: Direction From Bihar State, India

Henry W Murray MDDepartment of Medicine, Weill Cornell Medical College, 1300 York Avenue, NY 10065, USA. Correspondence[email protected]
View further author information
Pages 1301-1303 | Published online: 22 Sep 2010

Bibliography

  • Murray HW , BermanJD, DaviesCR, SaraviaNG: Advances in leishmaniasis.Lancet366 , 1561–1577 (2005).
  • Syriopoulou V , DaikosGL, TheodoridouMet al. : Two doses of a lipid formulation of amphotericin B for the treatment of Mediterranean visceral leishmaniasis.Clin. Infect. Dis.36 , 560–566 (2003).
  • Sundar S , ChakravartyJ, RaiVKet al. : Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.Clin. Infect. Dis.45 , 556–561 (2007).
  • Sundar S , JhaTK, ThakurCP, MishraM, SinghVR, BuffelsR: Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.Am. J. Trop. Med. Hyg.66 , 143–146 (2002).
  • Sundar S , MehtaH, SureshAV, SinghSP, RaiM, MurrayHW: Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.Clin. Infect. Dis.38 , 377–383 (2004).
  • Sundar S , JhaTK, ThakurCPet al. : Oral miltefosine for Indian visceral leishmaniasis.N. Engl. J. Med.347 , 1739–1746 (2002).
  • Sundar S , JhaTK, ThakurCP, SinhaPK, BhattacharyaSK: Injectable paromomycin for visceral leishmaniasis in India.N. Engl. J. Med.356 , 2571–2581 (2007).
  • Sundar S , RaiM, ChakravartyJet al. : New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.Clin. Infect. Dis.47 , 1000–1006 (2008).
  • Sundar SD , ChakravartyJ, AgarwalD, RaiM, MurrayHW: Single-dose liposomal amphotericin B for visceral leishmaniasis in India.N. Engl. J. Med.362 , 504–512 (2010).
  • Mondal D , SinghSP, KumarNet al. : Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.PLoS Negl. Trop. Dis.3 , e355 (2009).
  • den Boer ML , AlvarJ, DavidsonRN, RitmeijerK, BalasegaramM: Developments in the treatment of visceral leishmaniasis.Expert Opin. Emerg. Drugs124 , 395–410 (2009).
  • Bhattacharya SK , SinhaPK, SundarSet al. : Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.J. Infect. Dis.196 , 591–598 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.